KRAS subset analysis from randomized phase II trials of erlotinib versus erlotinib plus sorafenib or pazopanib in refractory non-small cell lung cancer (NSCLC) von Waterhouse, David Michael, Stults, Dawn Michelle, Daniel, Davey B., Griner, Paula L., Greco, F Anthony, Burris, Howard A., Hainsworth, John D., Spigel, David R.

Volltext

Everolimus with paclitaxel plus bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC): A randomized, double-blind, placebo-controlled phase II trial of... von Yardley, Denise Aysel, Bosserman, Linda D., Peacock, Nancy Walker, Favret, Anne, Morgan, Susan Kay, Priego, Victor M., Bass, J. David, Griner, Paula L., Burris, Howard A., Hainsworth, John D., O'Shaughnessy, Joyce

Volltext

Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer von Spigel, David R., Hainsworth, John D., Barton, John H., Patton, Jeffrey F., Zubkus, John D., Simons, Lisa, Griner, Paula, Burris, Howard A., Greco, F. Anthony

Volltext

Incidence of Hollow Viscus Injury in Blunt Trauma: An Analysis from 275,557 Trauma Admissions from the EAST Multi-Institutional Trial von Watts, Dorraine D., Fakhry, Samir M.

Volltext

Improving mammography screening von Benzel, Janice L, Laubach, Paula D, Griner, England, Faria, Mary F, Brunner, Tara J, Johnson, Julie R, Valley, Whitney M

Volltext

Improving Mammography Screening: Moving TCAB beyond medical—surgical units von Benzel, Janice L., Laubach, Paula D., Griner, England, Faria, Mary F., Brunner, Tara J., Johnson, Julie R., Valley, Whitney M.

Volltext